Cell therapy has emerged as one of the most promising frontiers in biopharmaceutical innovation, offering potential cures for diseases once considered untreatable. Yet, developing these personalized therapies presents a unique set of challenges, particularly for early-stage biotech companies navigating complex scientific, manufacturing, and regulatory hurdles. The Cell Therapy Manufacturing Center (CTMC) is pioneering a new approach by integrating development, manufacturing, regulatory, and clinical logistics under one roof — creating a truly end-to-end ecosystem designed to accelerate therapies from the lab bench to patient care.
Access the article: Discover Pharma